Selective serotonin reuptake inhibitor

[Efficacy of Universal and Selective Prevention on Depression in Children and Adolescents. a Systematic Review].

[Efficacy of universal and selective prevention on depression in children and adolescents. A systematic review].

Filed under: Depression Treatment

Z Kinder Jugendpsychiatr Psychother. 2012 Nov; 40(6): 385-97
Schulte-Körne G, Schiller Y

Objective: Unipolar depressive disorder often begins in childhood,… Continue reading

What Is the Difference in the Number of Positive Responders to SSRI’s and Placebo?

Question by : What is the difference in the number of positive responders to SSRI’s and placebo?
In clinical trials what is on average the difference in the number of positive responders between SSRIs and placebo for the treatment of… Continue reading

Depression Treatment: Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis.

Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.

Filed under: Depression Treatment

PLoS Med. 2012 Oct; 9(10): e1001326
Tansey KE, Guipponi M, Perroud N, Bondolfi… Continue reading

Depression Treatment: Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease With Comorbid Depression : A Meta-Analysis of Depression and Cognitive Outcomes.

Effect of selective serotonin reuptake inhibitors in Alzheimer’s disease with comorbid depression : a meta-analysis of depression and cognitive outcomes.

Filed under: Depression Treatment

Drugs Aging. 2012 Oct; 29(10): 793-806
Sepehry AA, Lee PE, Hsiung GY, Beattie BL, Jacova… Continue reading

Fears of Compassion and Happiness in Relation to Alexithymia, Mindfulness, and Self-Criticism.

Fears of compassion and happiness in relation to alexithymia, mindfulness, and self-criticism.

Filed under: Depression Treatment

Psychol Psychother. 2012 Dec; 85(4): 374-90
Gilbert P, McEwan K, Gibbons L, Chotai S, Duarte J, Matos M

Background.?There is increasing research to… Continue reading

PILOT RANDOMIZED TRIAL of a CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM for PATIENTS WITH MOOD DISORDERS.

PILOT RANDOMIZED TRIAL OF A CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM FOR PATIENTS WITH MOOD DISORDERS.

Filed under: Depression Treatment

Depress Anxiety. 2012 Oct 17;
Kilbourne AM, Li D, Lai Z, Waxmonsky J, Ketter T

OBJECTIVES: Chronic care models improved outcomes… Continue reading

United States — the Threat of Malpractice. How Much Does It Contribute…?

Question by titou: United States — The threat of malpractice. How much does it contribute…?
…to MDs “herding” into prescribing the same diagnosis, treatment and particularly medication?

I am thinking particularly of psychiatry, but perhaps this phenomenon happens in… Continue reading

Eating Disorders Facts: Eating Disorders: Facts About Eating Disorders and the Search for Solutions

Eating is controlled by many factors, including appetite, food availability, family, peer, and cultural practices. Attempts at voluntary control. Dieting to a body weight leaner than needed for health is highly promoted by current fashion trends, sales campaigns for special… Continue reading

Current and Emerging Directions in the Treatment of Eating Disorders.

Current and emerging directions in the treatment of eating disorders.

Filed under: Eating Disorders

Subst Abuse. 2012; 6: 33-61
Brown TA, Keel PK

Eating disorders are a significant source of psychiatric morbidity in young women and demonstrate high comorbidity… Continue reading

ACS Chemical Neuroscience Molecule Spotlight on Viibryd (Vilazodone).

ACS Chemical Neuroscience Molecule Spotlight on Viibryd (Vilazodone).

Filed under: Depression Treatment

ACS Chem Neurosci. 2011 Oct 19; 2(10): 554
Hopkins CR

On January 21, 2011, the U.S. Food and Drug Administration approved Viibryd, a new selective serotonin reuptake… Continue reading